Abstract
Introduction
Mutations of the skeletal muscle sodium channel gene SCN4A are associated with several neuromuscular disorders including hyper/hypokaliemic periodic paralysis, paramyotonia congenita and sodium channel myotonia. These disorders are distinguished from dystrophic myotonias by the absence of progressive weakness and extramuscular systemic involvement.
Methods
We present an Italian family with 2 subjects carrying a p.Asn1180Ile mutation in SCN4A gene showing a peculiar clinical picture characterized by the association of myopathic features and myotonia.
Results
The clinical, electromyographic and histological findings of these patients are reported. The possible pathogenicity of the mutation was tested by three different software, all giving positive results.
Discussion
This is the first report of a dominant, heterozygous mutation in SCN4A causing a complex phenotype of non-congenital myopathy and myotonic syndrome. We suggest that, in patients with myotonia and myopathy not related to dystrophic myotonias, the sequence analysis of SCN4A gene should be performed.
This is a preview of subscription content, log in via an institution to check access.
References
Matthews E, Fialho D, Tan SV, Venance SL, Cannon SC, Sternberg D et al (2010) The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain 133:9–22
Stunnenberg BC, LoRusso S, Arnold WD, BarohnRJ CSC, Fontaine B et al (2020) Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle Nerve 62(4):430–444
Fournier E, Viala K, Gervais H, Sternberg D, Arzel-Hézode M, Laforêt P et al (2006) Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol 60(3):356–365
Valaperta R, Lombardi F, Cardani R, Fossati B, Brigonzi E, Merli I et al (2015) Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2. Genet Test Mol Biomarkers 19(12):703–9
Galimberti V, Tironi R, Lerario A, Scali M, Del Bo R, Rodolico C et al (2020) Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy. Eur J Neurol 27:709–715
Fusco C, Frattini D, Salerno GG, Canali E, Bernasconi P, Maggi L (2015) New phenotype and neonatal onset of sodium channel myotonia in a child with a novel mutation of SCN4A gene. Brain Dev 37(9):891–893
Pan X, Li Z, Zhou Q, Shen H, Wu K, Huang X et al (2018) Structure of the human voltage-gated sodium channel Nav1.4 in complex with β1. Science 19;362(6412)
Depienne C, Trouillard O, Gourfinkel-An I, Saint-Martin C, Bouteiller D, Graber D et al (2010) Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J Med Genet 47(6):404–410
Trip J, Drost G, Ginjaar HB, Nieman FH, van der Kooi AJ, de Visser M et al (2009) Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. J Neurol Neurosurg Psychiatry 80(6):647–652
Pereon Y, Lande G, Demolombe S, TichS NT, Sternberg D et al (2003) Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization. Neurology 60:340–342
Brancati F, Valente EM, Davies NP, Sarkozy A, Sweeney MG, LoMonaco M et al (2003) Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J Neurol Neurosurg Psychiatry 74:1339–1341
Bissay V, Van Malderen SC, Keymolen K, Lissens W, Peeters U, Daneels D et al (2016) SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies. Eur J Hum Genet 24:400–407
Maggi L, Brugnoni R, Canioni E, Tonin P, Saletti V, Sola P et al (2020) Clinical and molecular spectrum of myotonia and periodic paralyses associated with mutations in SCN4A in a large cohort of Italian patients. Front Neurol 11:646
Zaharieva IT, Thor MG, Oates EC, van Karnebeek C, Hendson G, Blom E et al (2016) Loss of function mutations in SCN4A cause severe foetal hypokinesia or “classical” congenital myopathy. Brain 139:674–91
Mercier S, Lornage X, Malfatti E, Marcorelles P, Letournel F, Boscher C et al (2017) Expanding the spectrum of congenital myopathy linked to recessive mutations in SCN4A. Neurology 88(4):414–416
Waldrop M, Amornvit J, Pierson CR, Boue DR, Sahenk Z (2019) A novel de novo heterozygous SCN4a mutation causing congenital myopathy, myotonia and multiple congenital anomalies. Neuromuscul Dis 6(4):467–473
Elia N, Nault T, McMillan HJ, Graham GE, Huang L, Cannon SC (2020) Myotonic myopathy with secondary joint and skeletal anomalies from the c.2386C>G, p.L769V mutation in SCN4A. Front Neurol 11:77
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None
Ethical approval
None
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rigamonti, A., Mantero, V., Peverelli, L. et al. p.Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome. Neurol Sci 42, 5359–5363 (2021). https://doi.org/10.1007/s10072-021-05537-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05537-z